Intrivo
Biotechnology ResearchFlorida, United States11-50 Employees
Intrivo is a Miami, Florida-based biotechnology research company focused on digital health tools and health information that guide people through their health journeys. In response to the COVID-19 pandemic, it has emphasized rapid testing to help workplaces reopen and individuals reconnect, and it serves as the exclusive U.S. commercialization partner for Access Bio, bringing the CareStart family of tests to the market. The CareStart antigen test provides results in 10 minutes without the need for additional equipment. Its customers include individuals and organizations seeking convenient at-home testing and related health resources, addressing the need for quick diagnostics and guidance during illness or recovery, including long COVID. The company sits at the intersection of biotechnology research and consumer health technology, focusing on rapid diagnostics and supportive services. Based in the Miami area and characterized as a small- to mid-sized enterprise, Intrivo launched a free at-home Test to Treat program in 2022.